2017 Hypertension Guidelines Increase Other Patient Risks

Controversial hypertension guidelines raise risk of kidney failure and syncope.

Treating Mitral Valve Disease Sooner May Improve Outcomes

Many patients with mitral valve disease are referred too late and receive treatment only after heart or lung damage has occurred, researchers say.

MI Rates Rise After Introduction of High-sensitivity Troponins

The rates of myocardial infarction (MI) diagnosis and treatment increased after the introduction of high-sensitivity cardiac troponins (hs-cTnT), with no impact on overall survival, researchers report.

Tips for Treating Patients With Borderline Ejection Fraction

Neither fish nor fowl: What works for HF patients with borderline ejection fraction?

New Analysis Refutes Association Between Heart Failure, Incident Cancer

Debate heats up on whether HF Is Linked to Increased Cancer Incidence.

Determining Which Patients are Optimal for Ablation, Cardioversion, Oral & Anticoagulant Treatments

Oussama Wazni, MD, section head of clinical cardiac electrophysiology at Cleveland Clinic, discusses which treatments are best for patients who exhibit symptoms of atrial fibrillation.

Prognosis "Extremely Poor" in ESRD Patients Receiving LVAD for Heart Failure

Do LVADs offer the same mortality benefits in patients with both heart failure and end-stage renal disease? A new study explores the question.

ACC 2018: COMPASS Trial Finds Combination of Rivaroxaban & Aspirin Significantly Lowers Major Adverse Limb Events in Patients With PAD

COMPASS trial finds that a combination of rivaroxaban and aspirin are more effective for PAD patients than aspirin alone.

Who Requires Medication under New ACC/AHA Hypertension Guidelines?

New guidelines dramatically increase the number of patients with hypertension. Do they all need medication?

Patients Most Likely to Die of Cardiac Arrest During Weeknights & Weekends, Study Finds

A new study finds that patients who go into in-hospital cardiac arrest (IHCA) during the weekend have a lower chance of survival compared to those who are admitted to the hospital during a weekday.

Ablation in Patients with Atrial Fibrillation

According to the American College of Cardiology, ablation is the first-line treatment for atrial fibrillation. Dr. Oussama Wazni weighs the pros and cons of this treatment option.

American College of Cardiology Issues New Atrial Fibrillation Treatment Guidelines

  • Use the CHA2DS2-VASc score for determining which patients are at greatest risk of stroke.
  • Clinicians should take an individualized approach to antithrombotic therapy.
  • Strict rate control is preferred over lenient.
  • Catheter ablation is a first-line option.

Treatment Choices in Atrial Fibrillation

Managing atrial fibrillation to prevent stroke: Use nothing or an oral anticoagulant. Use the CHA2DS2-VASc algorithm as well as gender to determine treatment choices. Dr. Wazni presents treatment choices in further detail.

Managing Atrial Fibrillation and Preventing Stroke

Patients with atrial fibrillation are seen with increasing frequency by clinicians. Can it be cured? How must it be managed? How can clinicians prevent stroke in patients with a-fib? Dr. Wazni addresses these questions in our latest video.

Let the Patient Decide: Postoperative A-Fib Rhythm and Rate Strategies Are Equivalent

  • New multinational study of more than 500 patients found no clear superiority of either strategy.
  • The incidence of serious thromboembolic events was low, 2%, and did not differ between the arms.
  • More patients in the rate control arm met protocol-specified indications for anticoagulation compared with the rhythm control arm.

© 2024 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use | Editorial Policy | Advertising Policy